Trial Profile
Observational study of pirfenidone in patients with idiopathic pulmonary fibrosis treated at a pneumological referral centre in Germany
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 13 Nov 2015
Price :
$35
*
At a glance
- Drugs Pirfenidone (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Therapeutic Use
- 13 Nov 2015 New trial record